FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

116352007: Oxycodone terephthalate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
177294016 Oxycodone terephthalate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
677627015 Oxycodone terephthalate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
6916091000241119 téréphtalate d'oxycodone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxycodone terephthalate Is a Oxycodone false Inferred relationship Some
Oxycodone terephthalate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Opioid receptor agonist (disposition) true Inferred relationship Some
Oxycodone terephthalate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Oxycodone true Inferred relationship Some
Oxycodone terephthalate Is a Morphinan opioid true Inferred relationship Some
Oxycodone terephthalate Is a Central depressant true Inferred relationship Some
Oxycodone terephthalate Is a Analgesic (substance) true Inferred relationship Some
Oxycodone terephthalate Is a Drug pseudoallergen by function false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxycodone terephthalate Inferred relationship Some
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxycodone terephthalate Inferred relationship Some
Product containing aspirin and oxycodone hydrochloride and oxycodone terephthalate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxycodone terephthalate Inferred relationship Some
Product containing oxycodone terephthalate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxycodone terephthalate Inferred relationship Some
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxycodone terephthalate Inferred relationship Some 1
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Oxycodone terephthalate Inferred relationship Some 1
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Oxycodone terephthalate Inferred relationship Some 2
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Oxycodone terephthalate Inferred relationship Some 3
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oxycodone terephthalate Inferred relationship Some 3
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Oxycodone terephthalate Inferred relationship Some 3
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Oxycodone terephthalate Inferred relationship Some 3
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Oxycodone terephthalate Inferred relationship Some 2
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Oxycodone terephthalate Inferred relationship Some 1
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Oxycodone terephthalate Inferred relationship Some 1
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Oxycodone terephthalate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start